BK polyomavirus antigens

BK virus antigens encompass the viral proteins produced by the BK polyomavirus (Human polyomavirus 1). These antigens stimulate host immune responses and are primarily relevant for diagnostic and immune monitoring purposes in kidney and bone marrow transplant recipients. The proteins include the major capsid protein VP1 and others encoded by the viral genome, but they are not therapeutic targets themselves. The principal clinical significance of BK virus antigens is in their role as markers for viral infection and reactivation, especially in immunosuppressed individuals, where screening for the virus is essential to prevent allograft loss and severe dysfunction[1][2][3][6]. No defined drugs directly interact with these antigens, and immune responses (e.g., T-cell epitopes) serve as the main basis for biomarker development[4][5]. This term is best considered too broad and is not a canonical drug target or receptor; rather, individual BK virus proteins (such as VP1) may be named and studied as antigens for diagnostic, vaccine, or immune monitoring purposes.

Other names

Human polyomavirus 1 antigensBK virus proteinsBKV antigens

N/A (No drugs with established mechanisms targeting these antigens)